Cargando…

Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review

Detalles Bibliográficos
Autores principales:	Terry, Kathryn L., Sluss, Patrick M., Skates, Steven J., Mok, Samuel C., Ye, Bin, Vitonis, Allison F., Cramer, Daniel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2004
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839278/ https://www.ncbi.nlm.nih.gov/pubmed/15322314 http://dx.doi.org/10.1155/2004/241982

Ejemplares similares

The Association Between Talc Use and Ovarian Cancer: A Retrospective Case–Control Study in Two US States
por: Cramer, Daniel W., et al.
Publicado: (2016)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk
por: Cramer, Daniel W., et al.
Publicado: (2017)

Markers of Angiogenesis in Ovarian Cancer
por: Merritt, William M., et al.
Publicado: (2007)

Comprehensive phenotyping and biological marker discovery
por: Kantor, Aaron B.
Publicado: (2002)

Non-Genomic Biomarkers of Risk in Ovarian Cancer
por: Pinheiro, Simone P., et al.
Publicado: (2007)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Dietary fat intake and risk of epithelial ovarian cancer by tumour histology
por: Merritt, M A, et al.
Publicado: (2014)

Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium
por: Zhang, Lifang, et al.
Publicado: (2010)

Autoantibody Signature for the Serologic Detection of Ovarian Cancer
por: Anderson, Karen S., et al.
Publicado: (2014)

Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation
por: Jung, Alesia M., et al.
Publicado: (2021)

Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer
por: Brinkhuis, Mariël, et al.
Publicado: (2002)

Spontaneous Apoptosis, Oxidative Status and Immunophenotype Markers in Blood Lymphocytes of AIDS Patients
por: Losa, Gabriele A., et al.
Publicado: (2000)

Overexpression of Gastrin-Releasing Peptide Receptors in Tumor-Associated Blood Vessels of Human Ovarian Neoplasms
por: Fleischmann, Achim, et al.
Publicado: (2007)

Changing the use of isolated urine-culture testing with diagnostic testing stewardship
por: Penney, Jessica, et al.
Publicado: (2022)

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

Immunological Markers of Lung Disease Due to Non-Tuberculous Mycobacteria
por: Lim, Andrew, et al.
Publicado: (2010)

Comparison of Serum and Urine as Sources of miRNA Markers for the Detection of Ovarian Cancer
por: Kupec, Tomas, et al.
Publicado: (2023)

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer
por: Elias, Kevin M, et al.
Publicado: (2017)

The relationship of blood- and urine-boron to boron exposure in borax-workers and usefulness of urine-boron as an exposure marker.
por: Culver, B D, et al.
Publicado: (1994)

Early Detection of Ovarian Cancer
por: Badgwell, Donna, et al.
Publicado: (2007)

Claudin Proteins in Ovarian Cancer
por: Morin, Patrice J.
Publicado: (2007)

Aging markers in human urine: A comprehensive, non‐targeted LC‐MS study
por: Teruya, Takayuki, et al.
Publicado: (2020)

The Value of Combined Use of Survivin mRNA and Matrix Metalloproteinase 2 and 9 for Bladder Cancer Detection in Voided Urine
por: Eissa, Sanaa, et al.
Publicado: (2013)

Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer
por: Page, Robert E., et al.
Publicado: (2007)

Biomarkers of Mucinous Tumors of the Ovary
por: Samimi, Goli, et al.
Publicado: (2007)

Elevated Levels of miR-146a and miR-155 in Kidney Biopsy and Urine from Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2011)

Over-Expression of Dopamine D(2) Receptor and Inwardly Rectifying Potassium Channel Genes in Drug-Naive Schizophrenic Peripheral Blood Lymphocytes as Potential Diagnostic Markers
por: Zvara, Ágnes, et al.
Publicado: (2005)

Prognostic and Predictive Markers in Cancer
por: Conley, Barbara A., et al.
Publicado: (2004)

Carbohydrate Markers in Colon Carcinoma
por: Szajda, Sławomir Dariusz, et al.
Publicado: (2008)

Familial ovarian screening – effective or ineffective?
por: Jacobs, I J, et al.
Publicado: (2006)

Intracranial Anatomical Triangles: A Comprehensive Illustrated Review
por: Drazin, Doniel, et al.
Publicado: (2017)

The Diploic Veins: A Comprehensive Review with Clinical Applications
por: Lachkar, Stefan, et al.
Publicado: (2019)

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
por: Goodison, Steve, et al.
Publicado: (2013)

The Use of Plasma and Urine Neutrophil Gelatinase Associated Lipocalin (NGAL) and Cystatin C in Early Diagnosis of Septic Acute Kidney Injury in Critically Ill Patients
por: Aydoğdu, Müge, et al.
Publicado: (2013)

Urine markers and prostate cancer
por: Wilkosz, Jacek, et al.
Publicado: (2011)

In Vivo Measurement of Phosphorous Markers of Disease
por: Arias-Mendoza, Fernando, et al.
Publicado: (2004)

Development Tracks for Cancer Prevention Markers
por: Baker, Stuart G., et al.
Publicado: (2004)

Helicobacter pylori: Determinant and Markers of Virulence
por: Mascellino, M. T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fp8sll6ea2eltpqnf6tmlh6jko